Association between multiple sclerosis and HLA class II and antigen-processing genes in a Shanghai population

Chinese Journal of Microbiology and Immunology

Volumn 19, Issue 5, 1999, Pages 406-409

  Zhang, Yong ^a   Zhu, Xiaochun ^b   Shen, Fanxia ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

Antigen processing genes; HLA class II; Multiple sclerosis

Indexed keywords

EID: 0040205659     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Powis SH, Rosenberg WMC, Hall M, et al. TAP1 and TAP2 polymorphism in celiac disease. Immunogenetics, 1993, 38: 345-350.
2. Chevier D, Ciral M, Braud V, et al. Membranous nephropathy and a TAP1 gene polymorphism. N Engl J Med, 1994, 331: 133-134.
3. Roninfen KS, Undlien DE, Ploski R, et al. Linkage disequilibrium between TAP2 variants and insulin-dependent diabetes mellitus. J Immunol, 1993, 23: 1050-1054.
4. Ota M, Seki T, Nomura N, et al. Modified PCR-RFLP method for HLA-DPB1 and DQA1 genotyping. Tissue Antigens, 1991, 38: 60-71.
5. Sengar DPS, Goldstein R. Comprehensive typing of DQB1 alleles by PCR-RFLP. Tissue Antigens, 1994, 43: 242-248.
6. Ota M, Seki T, Fukushima H, et al. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens, 1992, 39: 187-202.
7. Den GY, Muir A, Maclaren NK, et al. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet, 1995, 56: 528-534.
8. Mattius PL, Ihde D, Piazza A, et al. New approaches to the population genetics and aggregation analysis of the HLA system. Histocompatibility Testing 1980. Terasaki PI, P193. Munksgaard, Copenhagen 1980.
9. Liblau R, PM van Endert , M Sandberg-Wollheim, et al. Antigen processing gene polymorphism in HLA-DR2 multiple sclerosis. Neurology, 1993, 43: 1192-1197.
10. Marrosu MG, Muntini F, Murru MR, et al. Sardinian multiple sclerosis is associated with HLA-DR4: A serologie & molecular analysis. Neurology, 1988, 38: 1749-1753.
11. Yagub BA, Daif AK. Multiple sclerosis in Saudi Arabia. Neurology, 1988, 38: 621-623.
12. Spurkland A, Tabira T, Renningen KS, et al. HLA-DRB1, -DQA1, -DQB1, -DPA1, -DPB1 genes in Japanese multiple sclerosis patients. Tissue Antigens, 1991, 37: 171-173.
13. Lightstone L, Hargreaves R, Bobek G, et al. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc Natl Acad Sci USA, 1997, 94: 5772-5777. O&H: 1998-09-25 £0:1999-01-11)